Skip to content
10-Q

Quarterly Report

Celldex Therapeutics, Inc. CLDX

0001410578-25-001610

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 28, 2025 66.41M sh
Shares Diluted Q2 2025 · Jun 30, 2025 66.39K sh
Shares Diluted Q2 2025 · Jun 30, 2025 66.39K sh
Shares Diluted Q2 2025 · Jun 30, 2024 66.02K sh
Shares Diluted Q2 2025 · Jun 30, 2024 62.45K sh
Capex Q2 2025 · Jun 30, 2025 $993K
Capex Q2 2025 · Jun 30, 2024 $618K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$98.38M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$69.97M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $23.04M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $28.36M
Stockholders Equity Q2 2025 · Jun 30, 2025 $655.41M
Stockholders Equity Q2 2025 · Mar 31, 2025 $702.98M
Stockholders Equity Q2 2025 · Dec 31, 2024 $747.01M
Stockholders Equity Q2 2025 · Jun 30, 2024 $813.66M
Stockholders Equity Q2 2025 · Mar 31, 2024 $838.61M
Stockholders Equity Q2 2025 · Dec 31, 2023 $429.17M
Current Liabilities Q2 2025 · Jun 30, 2025 $32.96M
Current Liabilities Q2 2025 · Dec 31, 2024 $39.5M
Total Liabilities Q2 2025 · Jun 30, 2025 $37M
Total Liabilities Q2 2025 · Dec 31, 2024 $45.34M
Current Assets Q2 2025 · Jun 30, 2025 $648.4M
Current Assets Q2 2025 · Dec 31, 2024 $747.16M
Total Assets Q2 2025 · Jun 30, 2025 $692.41M
Total Assets Q2 2025 · Dec 31, 2024 $792.34M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.85
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.66
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.54
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.10
Eps Basic Q2 2025 · Jun 30, 2025 −$0.85
Eps Basic Q2 2025 · Jun 30, 2025 −$1.66
Eps Basic Q2 2025 · Jun 30, 2024 −$0.54
Eps Basic Q2 2025 · Jun 30, 2024 −$1.10
Sga Expense Q2 2025 · Jun 30, 2025 $10.39M
Sga Expense Q2 2025 · Jun 30, 2025 $21.21M
Sga Expense Q2 2025 · Jun 30, 2024 $9.13M
Sga Expense Q2 2025 · Jun 30, 2024 $18.23M
Rd Expense Q2 2025 · Jun 30, 2025 $54.2M
Rd Expense Q2 2025 · Jun 30, 2025 $106.81M
Rd Expense Q2 2025 · Jun 30, 2024 $39.69M
Rd Expense Q2 2025 · Jun 30, 2024 $71.35M
Net Income Q2 2025 · Jun 30, 2025 −$56.6M
Net Income Q2 2025 · Jun 30, 2025 −$110.4M
Net Income Q2 2025 · Mar 31, 2025 −$53.8M
Net Income Q2 2025 · Jun 30, 2024 −$35.84M
Net Income Q2 2025 · Jun 30, 2024 −$68.65M
Net Income Q2 2025 · Mar 31, 2024 −$32.81M
Operating Income Q2 2025 · Jun 30, 2025 −$63.86M
Operating Income Q2 2025 · Jun 30, 2025 −$126.6M
Operating Income Q2 2025 · Jun 30, 2024 −$46.32M
Operating Income Q2 2025 · Jun 30, 2024 −$86.93M
Revenue Q2 2025 · Jun 30, 2025 $730K
Revenue Q2 2025 · Jun 30, 2025 $1.42M
Revenue Q2 2025 · Jun 30, 2024 $2.5M
Revenue Q2 2025 · Jun 30, 2024 $2.65M